Jiangsu Hengrui Medicine Co Ltd (600276):企業の財務・戦略的SWOT分析

◆英語タイトル:Jiangsu Hengrui Medicine Co Ltd (600276) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1683
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,125見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,375見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Jiangsu Hengrui Medicine Co Ltd (600276) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Jiangsu Hengrui Medicine Co Ltd (Jiangsu Hengrui) is a biopharmaceutical company that focuses on the research, development, manufacture and distribution of novel pharmaceutical products. Its product portfolio includes antineoplastic products, anti-tumor drugs, surgical drugs and contrast agents. The company offers products in therapeutic areas of central nervous system (CNS), musculoskeletal, metabolic, hematologic, infection, respiratory, cardiovascular, dermatology, gastrointestinal and oncology. Jiangsu Hengrui has manufacturing and R&D facilities in China, the US and Japan. The company offers products through its sales and distribution network across China. Jiangsu Hengrui is headquartered in Lianyungang, Jiangsu Province, China.

Jiangsu Hengrui Medicine Co Ltd Key Recent Developments

Feb 18,2020 Hengrui Medicine donated another 3 million yuan worth of innovative medicine to aid Hubei
Jan 25,2020 Hengrui Pharmaceutical donated RMB 5 million in special donations and medical protection materials
Jun 18,2019 Mycovia and Hengrui Medicine to commercialise VT-1161 for RVVC

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Jiangsu Hengrui Medicine Co Ltd – Key Facts
Jiangsu Hengrui Medicine Co Ltd – Key Employees
Jiangsu Hengrui Medicine Co Ltd – Key Employee Biographies
Jiangsu Hengrui Medicine Co Ltd – Major Products and Services
Jiangsu Hengrui Medicine Co Ltd – History
Jiangsu Hengrui Medicine Co Ltd – Company Statement
Jiangsu Hengrui Medicine Co Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Jiangsu Hengrui Medicine Co Ltd – Business Description
R&D Overview
Jiangsu Hengrui Medicine Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Jiangsu Hengrui Medicine Co Ltd – Strengths
Jiangsu Hengrui Medicine Co Ltd – Weaknesses
Jiangsu Hengrui Medicine Co Ltd – Opportunities
Jiangsu Hengrui Medicine Co Ltd – Threats
Jiangsu Hengrui Medicine Co Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Jiangsu Hengrui Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Jiangsu Hengrui Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Jiangsu Hengrui Medicine Co Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 18, 2020: Hengrui Medicine donated another 3 million yuan worth of innovative medicine to aid Hubei
Jan 25, 2020: Hengrui Pharmaceutical donated RMB 5 million in special donations and medical protection materials
Jun 18, 2019: Mycovia and Hengrui Medicine to commercialise VT-1161 for RVVC
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Jiangsu Hengrui Medicine Co Ltd, Key Facts
Jiangsu Hengrui Medicine Co Ltd, Key Employees
Jiangsu Hengrui Medicine Co Ltd, Key Employee Biographies
Jiangsu Hengrui Medicine Co Ltd, Major Products and Services
Jiangsu Hengrui Medicine Co Ltd, History
Jiangsu Hengrui Medicine Co Ltd, Subsidiaries
Jiangsu Hengrui Medicine Co Ltd, Joint Venture
Jiangsu Hengrui Medicine Co Ltd, Key Competitors
Jiangsu Hengrui Medicine Co Ltd, Ratios based on current share price
Jiangsu Hengrui Medicine Co Ltd, Annual Ratios
Jiangsu Hengrui Medicine Co Ltd, Annual Ratios (Cont...1)
Jiangsu Hengrui Medicine Co Ltd, Annual Ratios (Cont...2)
Jiangsu Hengrui Medicine Co Ltd, Interim Ratios
Jiangsu Hengrui Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Jiangsu Hengrui Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Jiangsu Hengrui Medicine Co Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Jiangsu Hengrui Medicine Co Ltd, Performance Chart (2015 - 2019)
Jiangsu Hengrui Medicine Co Ltd, Ratio Charts
Jiangsu Hengrui Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Jiangsu Hengrui Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Jiangsu Hengrui Medicine Co Ltd (600276):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • International Zeolite Corp:企業の戦略・SWOT・財務分析
    International Zeolite Corp - Strategy, SWOT and Corporate Finance Report Summary International Zeolite Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • SOSINA Exploration Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Sosina Exploration Ltd (Sosina), formerly Odegaard UK Ltd is an oil and gas company that offers exploration and development services. The company identifies probable oil and gas accumulations in co-operation with partners within the oil and gas industries. It provides services in geological …
  • Toronto Hydro Corp:企業の戦略的SWOT分析
    Toronto Hydro Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Netflix Inc.:企業の戦略・SWOT・財務分析
    Netflix Inc. - Strategy, SWOT and Corporate Finance Report Summary Netflix Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Pinsent Masons LLP:企業の戦略的SWOT分析
    Pinsent Masons LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Intra-Cellular Therapies Inc (ITCI):製薬・医療:M&Aディール及び事業提携情報
    Summary Intra-Cellular Therapies Inc (ITI) is a novel drug manufacturer. The company offers product platform such as ITCI Pipeline that includes lumateperone, ITI-007 platform, PDE inhibitor platform and drug discovery platform. The company’s lead product candidate ITI-007-lumateperone is to treat s …
  • AK Transneft (TRNFP):石油・ガス:M&Aディール及び事業提携情報
    Summary AK Transneft (Transneft) is a midstream oil and gas pipeline company that specializes in the transportation of crude oil and refined petroleum products. The company transports oil and oil products through trunk pipelines in the Russian Federation and outside. It carries out preventive mainte …
  • WABCO Holdings Inc.:企業の戦略・SWOT・財務分析
    WABCO Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary WABCO Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Honkarakenne Oyj (HONBS):企業の財務・戦略的SWOT分析
    Honkarakenne Oyj (HONBS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • IDL Biotech AB (IDL B):企業の財務・戦略的SWOT分析
    Summary IDL Biotech AB (IDL Biotech) is a biotechnology company that develops, manufactures and markets vitro diagnostic tests. The company offers products in the clinical areas of oncology and bacteriology. It offers vitro diagnostic tumor activity markers for common types of cancer which include b …
  • Assam Company India Ltd (ASSAMCO):企業の財務・戦略的SWOT分析
    Assam Company India Ltd (ASSAMCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Valero Energy Corp (VLO):企業の財務・戦略的SWOT分析
    Valero Energy Corp (VLO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • BioTime Inc (BTX)-医療機器分野:企業M&A・提携分析
    Summary BioTime Inc (BioTime) is a biotechnology company which focuses on regenerative medicine and plasma volume expanders. The company’s Hextend is a blood plasma volume expander used for the treatment of hypovolemia in surgery, emergency trauma treatment, and other applications. It is also develo …
  • Gran Tierra Energy Inc. (GTE)-石油・ガス分野:企業M&A・提携分析
    Summary Gran Tierra Energy Inc. (Gran Tierra) is an independent energy company. It acquires, explores, and develops oil and gas fields. The company produces crude oil, natural gas, and oil equivalent resources from its fields. Gran Tierra has onshore oil and gas properties in Colombia; and also owns …
  • Black River Electric Cooperative, Inc.:企業の発電所・SWOT分析2018
    Black River Electric Cooperative, Inc. - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informati …
  • Banyan Tree Holdings Ltd:企業の戦略・SWOT・財務情報
    Banyan Tree Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Banyan Tree Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Medical Developments International Ltd (MVP):製薬・医療:M&Aディール及び事業提携情報
    Summary Medical Developments International Ltd (MDI) is a healthcare company that develops, manufactures and markets pain relief and respiratory medicine. The company provides products such as penthrox, asthma and COPD, medical devices and veterinary products. It offers asthma and COPD products whic …
  • SPX Corporation:企業の戦略・SWOT・財務情報
    SPX Corporation - Strategy, SWOT and Corporate Finance Report Summary SPX Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Kaiser Foundation Health Plan of Washington:企業の戦略的SWOT分析
    Kaiser Foundation Health Plan of Washington - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • Enlight Renewable Energy Ltd (ENLT):企業の財務・戦略的SWOT分析
    Summary Enlight Renewable Energy Ltd (Enlight Renewable), a subsidiary of Eurocom Group, is a renewable energy company that invests, develops, finances, constructs, operates and manages electricity production projects from renewable energy sources. The company develops photovoltaic technology by whi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆